The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In Vitro
Objective: Aggregation of the TAU proteins in the form of neurofibrillary tangles (NFTs) in the brain is a common risk factor in tauopathies including Alzheimer’s disease (AD). Several strategies have been implemented to target NFTs, among which chaperones, which facilitate the proper folding of p...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Royan Institute (ACECR), Tehran
2017-11-01
|
Series: | Cell Journal |
Subjects: | |
Online Access: | http://celljournal.org/journal/article/16341/download |
id |
doaj-58dd7a86d594406197f6b24493399733 |
---|---|
record_format |
Article |
spelling |
doaj-58dd7a86d594406197f6b244933997332020-11-25T03:23:15ZengRoyan Institute (ACECR), TehranCell Journal2228-58062228-58142017-11-0119456957710.22074/cellj.2018.4510The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In VitroZahra Khosravi0Mohammad Ali Nasiri Khalili1Sharif Moradi2Reza Hassan Sajedi3Mehdi Zeinoddini4Department of Biosciences and Biotechnology, Malek Ashtar University of Technology, Tehran, IranDepartment of Biosciences and Biotechnology, Malek Ashtar University of Technology, Tehran, IranDepartment of Stem Cells and Developmental Biology, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, IranDepartment of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, IranDepartment of Biosciences and Biotechnology, Malek Ashtar University of Technology, Tehran, IranObjective: Aggregation of the TAU proteins in the form of neurofibrillary tangles (NFTs) in the brain is a common risk factor in tauopathies including Alzheimer’s disease (AD). Several strategies have been implemented to target NFTs, among which chaperones, which facilitate the proper folding of proteins, appear to hold great promise in effectively inhibiting TAU polymerization. The aim of this study was to analyze the impact of the chaperone Artemin on TAU aggregation in vitro. Materials and Methods: In this experimental study, recombinant TAU- or Artemin proteins were expressed in E.coli bacteria, and purified using ion-exchange and affinity chromatography. Sodium dodecyl sulfate-poly acrylamide gel electrophoresis (SDS-PAGE) was used to run the extracted proteins and check their purity. Heparin was used as an aggregation inducer. The interaction kinetics of TAU aggregation and disassembly was performed using thioflavin T (ThT) fluorescence analysis and circular dichroism (CD) spectroscopy. Results: Ion-exchange and affinity chromatography yielded highly pure TAU and Artemin proteins for subsequent analyses. In addition, we found that heparin efficiently induced TAU fibrillization 48 hours post-incubation, as evidenced by ThT assay. Importantly, Artemin was observed to effectively block the aggregation of both physiologic- and supraphysiologic TAU concentrations in a dose-dependent manner, as judged by ThT and CD spectroscopy analyses. Conclusion: Our collective results show, for the first time, that the chaperone Artemin could significantly inhibit aggregation of the TAU proteins in a dose-dependent manner, and support Artemin as a potential potent blocker of TAU aggregation in people with AD.http://celljournal.org/journal/article/16341/downloadAggregationAlzheimer’s DiseaseArteminChaperoneTAU Protein |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zahra Khosravi Mohammad Ali Nasiri Khalili Sharif Moradi Reza Hassan Sajedi Mehdi Zeinoddini |
spellingShingle |
Zahra Khosravi Mohammad Ali Nasiri Khalili Sharif Moradi Reza Hassan Sajedi Mehdi Zeinoddini The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In Vitro Cell Journal Aggregation Alzheimer’s Disease Artemin Chaperone TAU Protein |
author_facet |
Zahra Khosravi Mohammad Ali Nasiri Khalili Sharif Moradi Reza Hassan Sajedi Mehdi Zeinoddini |
author_sort |
Zahra Khosravi |
title |
The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In Vitro |
title_short |
The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In Vitro |
title_full |
The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In Vitro |
title_fullStr |
The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In Vitro |
title_full_unstemmed |
The Molecular Chaperone Artemin Efficiently Blocks Fibrillization of TAU Protein In Vitro |
title_sort |
molecular chaperone artemin efficiently blocks fibrillization of tau protein in vitro |
publisher |
Royan Institute (ACECR), Tehran |
series |
Cell Journal |
issn |
2228-5806 2228-5814 |
publishDate |
2017-11-01 |
description |
Objective: Aggregation of the TAU proteins in the form of neurofibrillary tangles (NFTs) in the brain is a common risk
factor in tauopathies including Alzheimer’s disease (AD). Several strategies have been implemented to target NFTs,
among which chaperones, which facilitate the proper folding of proteins, appear to hold great promise in effectively
inhibiting TAU polymerization. The aim of this study was to analyze the impact of the chaperone Artemin on TAU
aggregation in vitro.
Materials and Methods: In this experimental study, recombinant TAU- or Artemin proteins were expressed in E.coli
bacteria, and purified using ion-exchange and affinity chromatography. Sodium dodecyl sulfate-poly acrylamide gel
electrophoresis (SDS-PAGE) was used to run the extracted proteins and check their purity. Heparin was used as an
aggregation inducer. The interaction kinetics of TAU aggregation and disassembly was performed using thioflavin T
(ThT) fluorescence analysis and circular dichroism (CD) spectroscopy.
Results: Ion-exchange and affinity chromatography yielded highly pure TAU and Artemin proteins for subsequent
analyses. In addition, we found that heparin efficiently induced TAU fibrillization 48 hours post-incubation, as evidenced
by ThT assay. Importantly, Artemin was observed to effectively block the aggregation of both physiologic- and supraphysiologic
TAU concentrations in a dose-dependent manner, as judged by ThT and CD spectroscopy analyses.
Conclusion: Our collective results show, for the first time, that the chaperone Artemin could significantly inhibit
aggregation of the TAU proteins in a dose-dependent manner, and support Artemin as a potential potent blocker of TAU
aggregation in people with AD. |
topic |
Aggregation Alzheimer’s Disease Artemin Chaperone TAU Protein |
url |
http://celljournal.org/journal/article/16341/download |
work_keys_str_mv |
AT zahrakhosravi themolecularchaperonearteminefficientlyblocksfibrillizationoftauproteininvitro AT mohammadalinasirikhalili themolecularchaperonearteminefficientlyblocksfibrillizationoftauproteininvitro AT sharifmoradi themolecularchaperonearteminefficientlyblocksfibrillizationoftauproteininvitro AT rezahassansajedi themolecularchaperonearteminefficientlyblocksfibrillizationoftauproteininvitro AT mehdizeinoddini themolecularchaperonearteminefficientlyblocksfibrillizationoftauproteininvitro AT zahrakhosravi molecularchaperonearteminefficientlyblocksfibrillizationoftauproteininvitro AT mohammadalinasirikhalili molecularchaperonearteminefficientlyblocksfibrillizationoftauproteininvitro AT sharifmoradi molecularchaperonearteminefficientlyblocksfibrillizationoftauproteininvitro AT rezahassansajedi molecularchaperonearteminefficientlyblocksfibrillizationoftauproteininvitro AT mehdizeinoddini molecularchaperonearteminefficientlyblocksfibrillizationoftauproteininvitro |
_version_ |
1724606610414764032 |